大為股份(002213.SZ):目前大為創芯及其子公司部分存儲產品已使用長江存儲的方案
格隆匯1月4日丨有投資者於投資者互動平台向大為股份(002213.SZ)提問,“請問公司是否與長江存儲展開合作?”,公司回覆稱,公司全資子公司深圳市大為創芯微電子科技有限公司(簡稱“大為創芯”)主要產品有NAND、DRAM存儲兩大系列,為客户提供高性能、高品質的存儲產品。大為創芯及其子公司與主要存儲供應商均建立了長期商業關係,供應鏈較為多元化,目前,大為創芯及其子公司部分存儲產品已使用長江存儲的方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.